Publications by authors named "B Meignier"

Claim this Profile
S
Safety, immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate.
Audrey Ferrier-Rembert, Robert Drillien, Bernard Meignier, Daniel Garin, Jean-Marc Crance

Vaccine· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics and metabolic specificities of Vero cells in bioreactor cultures with serum-free medium.
Sébastien Quesney, Annie Marc, Catherine Gerdil, Cyrille Gimenez, Jacqueline Marvel, Bernard Meignier

Cytotechnology· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Industrial experience with live polio vaccine prepared on the Vero continuous cell line.
B Meignier

Dev Biol (Basel)· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Vero cell growth and death in bioreactor with serum-containing and serum-free media.
S Quesney, J Marvel, A Marc, C Gerdil, B Meignier

Cytotechnology· March 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection. AGIS Group and L'Agence Nationale de Recherches sur Le Sida.
D Salmon-Céron, J L Excler, L Finkielsztejn, B Autran, J C Gluckman, B Meignier

AIDS Res Hum Retroviruses· May 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis